|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 45, Issue 4 244-253, Copyright © 1995 by American Cancer Society
S. Hetelekidis, S. J. Schnitt, M. Morrow and J. R. Harris
The increased use of screening mammography in the past two decades has led
to a marked increase in the number of patients diagnosed with ductal
carcinoma in situ. Treatment has traditionally involved mastectomy, but
this approach has come under increasing scrutiny, and the treatment of
ductal carcinoma in situ has become one the most controversial areas in the
field of breast disease. This article reviews current concepts regarding
the diagnosis, natural history, and treatment of ductal carcinoma in situ.
ARTICLES
Management of ductal carcinoma in situ
Joint Center for Radiation Therapy, Harvard Medical School in Boston, Massachusetts, USA.
This article has been cited by other articles:
![]() |
C. Mazouni, F. Peintinger, S. Wan-Kau, F. Andre, A. M. Gonzalez-Angulo, W. F. Symmans, F. Meric-Bernstam, V. Valero, G. N. Hortobagyi, and L. Pusztai Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome J. Clin. Oncol., July 1, 2007; 25(19): 2650 - 2655. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kerlikowske, A. Molinaro, I. Cha, B.-M. Ljung, V. L. Ernster, K. Stewart, K. Chew, D. H. Moore II, and F. Waldman Characteristics Associated With Recurrence Among Women With Ductal Carcinoma In Situ Treated by Lumpectomy J Natl Cancer Inst, November 19, 2003; 95(22): 1692 - 1702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |